As of 2024-12-14, the Intrinsic Value of ABIOMED Inc (ABMD) is
123.50 USD. This Abiomed valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 381.02 USD, the upside of ABIOMED Inc is
-67.60%.
The range of the Intrinsic Value is 76.43 - 380.02 USD
123.50 USD
Intrinsic Value
Abiomed Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
76.43 - 380.02 |
123.50 |
-67.6% |
| DCF (Growth 10y) |
135.73 - 678.93 |
220.24 |
-42.2% |
| DCF (EBITDA 5y) |
98.30 - 273.25 |
169.33 |
-55.6% |
| DCF (EBITDA 10y) |
159.60 - 454.08 |
275.27 |
-27.8% |
| Fair Value |
147.90 - 147.90 |
147.90 |
-61.18% |
| P/E |
129.97 - 311.19 |
209.29 |
-45.1% |
| EV/EBITDA |
53.73 - 200.65 |
120.27 |
-68.4% |
| EPV |
51.38 - 66.87 |
59.13 |
-84.5% |
| DDM - Stable |
47.74 - 195.34 |
121.54 |
-68.1% |
| DDM - Multi |
57.90 - 191.14 |
89.71 |
-76.5% |
Abiomed Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
17,180.65 |
| Beta |
1.39 |
| Outstanding shares (mil) |
45.09 |
| Enterprise Value (mil) |
16,998.31 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.70% |
| Cost of Debt |
5.00% |
| WACC |
6.84% |